Evidence map›Paper›PMID 19451264›Full record

ArticleThe Journal of experimental medicine2009

iNKT cell development is orchestrated by different branches of TGF-beta signaling.

Jean-Marc Doisne, Laurent Bartholin, Kai-Ping Yan, Céline N Garcia, Nadia Duarte, Jean-Benoît Le Luduec, David Vincent, Farhan Cyprian, Branka Horvat, Sylvie Martel and 4 more

Abstract read
In one paragraph

Article in The Journal of experimental medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Innateness transcriptome gradients characterize mouse T lymphocyte populations.Journal of immunology (Baltimore, Md. : 1950) · 2025
    Article
  4. An intestinal TNature immunology · 2024
    Article
  5. The Immune Modulatory Role of TIF1 Proteins.Advances in experimental medicine and biology · 2024
    Review
  6. Article
  7. Article
  8. Review
  9. Markers and makers of NKT17 cells.Experimental & molecular medicine · 2023
    Review
  10. Article
  11. Cytolytic CD4Frontiers in immunology · 2022
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jean-Marc DoisneInstitut National de la Santé et de la Recherche Médicale, U561/Groupe AVENIR, Hôpital Cochin St Vincent de Paul, Université Descartes, Paris F-75014, France.
Laurent Bartholin
Kai-Ping Yan
Céline N Garcia
Nadia Duarte
Jean-Benoît Le Luduec
David Vincent
Farhan Cyprian
Branka Horvat
Sylvie Martel
Ruth Rimokh
Régine Losson
Kamel Benlagha
Julien C Marie

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Invariant natural killer T (iNKT) cells constitute a distinct subset of T lymphocytes exhibiting important immune-regulatory functions. Although various steps of their differentiation have been well characterized, the factors controlling their development remain poorly documented. Here, we show that TGF-beta controls the differentiation program of iNKT cells. We demonstrate that TGF-beta signaling carefully and specifically orchestrates several steps of iNKT cell development. In vivo, this multifaceted role of TGF-beta involves the concerted action of different pathways of TGF-beta signaling. Whereas the Tif-1gamma branch controls lineage expansion, the Smad4 branch maintains the maturation stage that is initially repressed by a Tif-1gamma/Smad4-independent branch. Thus, these three different branches of TGF-beta signaling function in concert as complementary effectors, allowing TGF-beta to fine tune the iNKT cell differentiation program.

Indexed as

AnimalsApoptosisCell DifferentiationCell LineageInterleukin-2 Receptor beta SubunitMiceMice, TransgenicNatural Killer T-CellsReceptors, Transforming Growth Factor betaSignal TransductionSmad4 ProteinSpleenStem CellsT-bet Transcription FactorT-Box Domain ProteinsT-Lymphocyte SubsetsInterleukin-2 Receptor beta SubunitReceptors, Transforming Growth Factor betaSmad4 ProteinSmad4 protein, mouseT-bet Transcription FactorT-Box Domain ProteinsTranscription FactorsTransforming Growth Factor betaTrim33 protein, mouse

Identifiers

PMID19451264
PMCPMC2715067

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.